Categories: News

Access Telehealth Partners with Respiri to Bring Remote Patient Monitoring to Children’s Hospital of Michigan

Partnership Creates First Program of its Kind in the US for Remote Monitoring of Asthma Symptoms and Chronic Respiratory Disease

CORAL SPRINGS, Fla., March 30, 2022 /PRNewswire-PRWeb/ — Access Telehealth is proud to announce a strategic partnership with Respiri Limited (ASX:RSH) to launch a novel Remote Patient Monitoring (RPM) pilot program at Children’s Hospital of Michigan. The program provides an RPM solution for children living with asthma by introducing the use of Respiri’s wheezo ® device to facilitate wheeze detection.

Myra Ameigh, President and CEO of Access Telehealth, shares, “We believe using wheeze detection with our RPM platform, Remotli, will be a game changer in managing chronic respiratory disease.”

Access Telehealth offers an innovative, HIPAA-compliant connected care platform and expert clinical staff to support Remote Patient Monitoring and Digital Medicine. Their leading edge technologies afford a low-cost and powerful way to improve access to care outside of the clinic and help patients successfully manage chronic disease. Configurable care protocols and intelligent automation provide clinicians with meaningful physiologic data and workflows to proactively manage patients, improving patient outcomes and reducing healthcare costs related to repeat hospitalizations and emergency care.

Currently 6 in 10 Americans live with at least one chronic disease, yet less than 3% of the nation’s health care dollars are spent on prevention. With this new partnership, Access Telehealth underscores its position as an industry leader, disrupting the status quo by introducing new digital health technology and innovative disease-specific RPM monitoring programs.

Children’s Hospital of Michigan, an affiliate of Central Michigan university, is one of the largest children’s hospitals in America. The hospital is located in metro Detroit, where approximately 70,000 children are living with asthma. With over 225 beds and extensive asthma outpatient services to serve their community, Children’s Hospital of Michigan is a premier healthcare service provider for the region.

Associate Professor Pavadee Poowuttikul, Division Chief of Allergy/Immunology and Rheumatology at Children’s Hospital of Michigan, is the lead in this initiative. She states, “We have been searching for new technologies that allow us to better monitor the management of our difficult-to-control, inner-city asthma patients once they leave our hospital and care. Many times, our patients and their families come to us without recognizing that they are actively wheezing or do not remember how often they have been wheezing in the last few months. wheezo® provides us with an easy and real time solution that should give us greater transparency around patient management from the real world where asthma problems occur. We are excited about this collaboration.”

Respiri is an e-Health SaaS company supporting respiratory health management based in Melbourne, Australia. Its world-first technology detects wheeze, a typical symptom of asthma, COPD and respiratory disease to provide an objective measure of airway limitation. wheezo® is an FDA approved medical device delivering wheeze rate and wheeze recordings for evaluation and management of patients.

CEO and Managing Director of Respiri, Mr. Marjan Mikel said, “We are very excited about this important RPM collaboration with the Children’s Hospital and Access Telehealth as it demonstrates that there is a strong acceptance of wheezo® as part of asthma management.”

Together, Access Telehealth and Respiri are positioned to transform chronic respiratory disease management for all patient populations living with Asthma, COPD and other respiratory conditions.

About Access Telehealth
Access Telehealth is a digital health company dedicated to delivering innovative connected care solutions for management of people living with chronic disease. Focusing on Remote Physiologic Monitoring and virtual care initiatives, the Access Telehealth clinical team delivers patient-centric remote monitoring services to support disease specific chronic care programs for health systems, payors and providers, to enhance care delivery. https://www.accessrpm.com/

For More Information:
Lisa Dye
844-527-7669 x708 ldye@accessrpm.com

Media Contact

Lori Heiselman, Biscuit Media Group, +1 7145535181, lori@biscuitmediagroup.com

Twitter, Facebook

 

SOURCE Access Telehealth

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

10 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

10 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago